SGS-742
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SGS-742, covering 2020-02-24 to 2020-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency [Phase 2]